Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T06:01:17.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T14:19:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The date has been updated from February 12, 2025, to April 17, 2025.
    Difference
    0.7%
    Check dated 2025-04-23T12:30:14.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T10:18:31.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025, while a date for March 25, 2025, has been removed.
    Difference
    1.0%
    Check dated 2025-04-09T04:47:09.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T19:02:13.000Z thumbnail image

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.